Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.3.0.814
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Revenues $ 160 $ 819
Operating expenses:    
Research and development (related party of $227 and $222) 551 1,185
General and administrative 1,422 1,050
Total operating expenses 1,973 2,235
Operating loss (1,813) (1,416)
Other income:    
Interest income 2 1
Royalty income 6 5
Total other income 8 6
Net loss (1,805) (1,410)
Comprehensive loss:    
Net loss (1,805) (1,410)
Other comprehensive loss - foreign currency translation adjustments (9) (3)
Comprehensive loss $ (1,814) $ (1,413)
Loss per common share - basic and diluted (in dollars per share) $ (0.02) $ (0.02)
Weighted-average common shares outstanding - basic and diluted (in shares) 77,307 65,859